Show simple item record

Prognostic features and treatment of endocervical adenocarcinoma of the cervix

dc.contributor.authorHopkins, Michael P.en_US
dc.contributor.authorSutton, Patricken_US
dc.contributor.authorRoberts, James A.en_US
dc.date.accessioned2006-04-07T19:53:22Z
dc.date.available2006-04-07T19:53:22Z
dc.date.issued1987-05en_US
dc.identifier.citationHopkins, Michael P., Sutton, Patrick, Roberts, James A. (1987/05)."Prognostic features and treatment of endocervical adenocarcinoma of the cervix." Gynecologic Oncology 27(1): 69-75. <http://hdl.handle.net/2027.42/26706>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WG6-4C5H09V-13W/2/30d23e38608e1c38e5744e765c2dbd66en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/26706
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3570050&dopt=citationen_US
dc.description.abstractAdenocarcinoma of the cervix represents an increasing percentage of cervical cancers as well as a controversial clinical problem. One hundred seventy-two cases of adenocarcinoma were treated at The University of Michigan Medical Center from 1970 to 1984, representing 16.8% of cervical cancers. Of this group 84 patients were diagnosed with endocervical columnar cell type and form the study population for this report. Survival was influenced by stage, grade, and nodal metastases. Age did not influence survival. Survival in stage I disease was not influenced by treatment modality. Radical surgery or radiation therapy provided equal survival and ovarian conservation did not adversely influence survival. Radical surgery can be considered a primary means of therapy in young women and offers the same advantages over radiation therapy as those offered for squamous cell disease.en_US
dc.format.extent436235 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titlePrognostic features and treatment of endocervical adenocarcinoma of the cervixen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbsecondlevelOphthalmologyen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Obstetrics and Gynecology University of Michigan, Ann Arbor, Michigan 48109, U.S.A.en_US
dc.contributor.affiliationumDepartment of Obstetrics and Gynecology University of Michigan, Ann Arbor, Michigan 48109, U.S.A.en_US
dc.contributor.affiliationumDepartment of Obstetrics and Gynecology University of Michigan, Ann Arbor, Michigan 48109, U.S.A.en_US
dc.identifier.pmid3570050en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/26706/1/0000256.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0090-8258(87)90231-9en_US
dc.identifier.sourceGynecologic Oncologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.